Last reviewed · How we verify
ANTI-ANGIN® FORMULA, topical metered spray
ANTI-ANGIN® FORMULA provides topical anesthetic and anti-inflammatory relief for sore throat and oral pain through local numbing and soothing agents.
ANTI-ANGIN® FORMULA provides topical anesthetic and anti-inflammatory relief for sore throat and oral pain through local numbing and soothing agents. Used for Sore throat pain relief, Pharyngitis symptom management, Minor oral and throat irritation.
At a glance
| Generic name | ANTI-ANGIN® FORMULA, topical metered spray |
|---|---|
| Sponsor | Sandoz |
| Drug class | Topical anesthetic/anti-inflammatory spray |
| Modality | Small molecule |
| Therapeutic area | Otolaryngology / Pain Management |
| Phase | Phase 3 |
Mechanism of action
The spray formulation delivers local anesthetic agents (likely benzocaine or similar) directly to the affected oral/pharyngeal tissues, providing rapid numbing of pain receptors. Additional anti-inflammatory and soothing components reduce local inflammation and irritation associated with sore throat, pharyngitis, or minor oral lesions.
Approved indications
- Sore throat pain relief
- Pharyngitis symptom management
- Minor oral and throat irritation
Common side effects
- Local irritation or sensitization
- Allergic reaction to spray components
- Temporary numbness of throat/tongue
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ANTI-ANGIN® FORMULA, topical metered spray CI brief — competitive landscape report
- ANTI-ANGIN® FORMULA, topical metered spray updates RSS · CI watch RSS
- Sandoz portfolio CI